Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ovid Therapeutics Inc OVID

Healthcare Biotechnology
Ovid Therapeutics Inc. is a biopharmaceutical company. The Company is focused on improving the lives of people affected by certain epilepsies and brain conditions with seizure symptoms. It is engaged in advancing a pipeline of novel, targeted small molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of seizures and other... see more

Recent & Breaking News (NDAQ:OVID)

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 4, 2024

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 8, 2024

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

GlobeNewswire February 28, 2024

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire February 6, 2024

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

GlobeNewswire December 1, 2023

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

GlobeNewswire November 3, 2023

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

GlobeNewswire October 18, 2023

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

GlobeNewswire October 10, 2023

Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

GlobeNewswire September 26, 2023

Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 20, 2023

Ovid Therapeutics to Participate in Upcoming September Investor Conferences

GlobeNewswire August 30, 2023

Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates

GlobeNewswire August 4, 2023

Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023

GlobeNewswire August 1, 2023

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

GlobeNewswire June 28, 2023

Ovid Therapeutics Added to Russell 3000® Index

GlobeNewswire June 26, 2023

Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

GlobeNewswire May 5, 2023

Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors

GlobeNewswire May 1, 2023

Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting

GlobeNewswire April 27, 2023

Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 10, 2023

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 13, 2023